Switch to
More onapp

How to use scorecard? Learn more

Dipna Pharmachem Ltd

DPL
Trading
SmallcapWith a market cap of ₹32 cr, stock is ranked 3,448
High RiskStock is 9.09x as volatile as Nifty
13.000.09 (+0.70%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Trading
SmallcapWith a market cap of ₹32 cr, stock is ranked 3,448
High RiskStock is 9.09x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
1.33
Dividend YieldDiv. Yield
Sector PESector PE
-26.78
Sector PBSector PB
0.60
Sector Div YldSctr Div Yld
0.33%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dipna Pharmachem Limited is an India-based trader, importer, and exporter of industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulations. The Company's product portfolio comprises approximately 61 APIs and AIPs intermediates, such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone and others. Its products include Aceclofenac, Asprin, Acetazolamide, Albendazole, Ambroxol HCL, Amisulpride IP/BP, Amoxicillin, Aripiprazole IP, Artemether, Azithromycin, Hydrocortisone Acetate, Ibuprofen Ip, Levofloxacin. Lumefantrine, Lidocaine Base, Lidocaine Hydrochloride, Lornoxicam, L Glutathione Reduced, L Glutamine, L Carnosine, L Arginine Base and others. It provides import/export services to clients throughout the world.

Financial TrendFinancial statements 

202020212022202330.5531.0272.7799.940.070.031.160.92
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 9.37%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Hmm, looks like data is unavailable here. Please come back after some time
See all events